1. 2020
  2. E-pub ahead of print
  3. E-pub ahead of print

    Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions

    Bokhari, F., Mariuzzo, F. & Bennato, A. R., 21 Apr 2020, In : Small Business Economics. 46 p.

    Research output: Contribution to journalArticle

  4. 2018
  5. Published
  6. 2017
  7. Published

    Can drug price hikes via debranding be prevented?

    Bokhari, F. & Lyons, B., Apr 2017, In : Prescriber. 28, 4, p. 44-46 3 p.

    Research output: Contribution to journalArticle

  8. 2014
  9. Published

    Selective admission into stroke unit and patient outcomes: a tale of four cities

    Bokhari, F., Wellwood, I., Rudd, A., Langhorne, P., Dennis, M. & Wolfe, C., 9 Jan 2014, In : Health Economics Review. 4, 1, p. 1-10 10 p.

    Research output: Contribution to journalArticle

  10. 2013
  11. Published

    What is the price of pay-to-delay deals?

    Bokhari, F. A. S., 1 Sep 2013, In : Journal of Competition Law and Economics. 9, 3, p. 739-753 15 p.

    Research output: Contribution to journalArticle

  12. Published

    Entry in the ADHD drugs market: Welfare impact of generics and me-toos

    Bokhari, F. & Fournier, G., 2013, In : Journal of Industrial Economics. 61, 2, p. 339–392

    Research output: Contribution to journalArticle

  13. 2011
  14. Published

    School accountability laws and consumption of psychostimulants

    Bokhari, F. & Schneider, H., 2011, In : Journal of Health Economics. 30, 2, p. 355-372 18 p.

    Research output: Contribution to journalArticle

  15. 2009
  16. Published
  17. 2008
  18. Published

    Risk factors for discontinuing drug therapy among children with ADHD

    Bokhari, F., Heiland, F., Levine, P. & Thomas Ray, G., Sep 2008, In : Health Services and Outcomes Research Methodology. 8, 3, p. 134-158 25 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next

ID: 46897